HIV treatment lasts a lifetime. There is currently no cure for HIV, and antiretroviral therapy (ART) must be taken continuously and without interruption to keep the virus suppressed. Stopping treatment, even briefly, allows the virus to rebound rapidly, lowering immune function and increasing the risk of illness and transmission.
That said, “lifelong” doesn’t mean the experience stays the same year after year. Treatment has become dramatically simpler, side effects have shrunk, and some newer options only require an injection every two months instead of a daily pill. Here’s what the timeline actually looks like.
Why Treatment Can’t Be Stopped
ART works by blocking HIV from making copies of itself inside your body. When it’s working well, the amount of virus in your blood drops so low that standard lab tests can’t detect it. This is called an undetectable viral load, and it’s the primary goal of treatment. Reaching and staying undetectable protects your immune system, prevents HIV-related complications, and allows you to live a lifespan approaching that of someone without HIV.
The critical word there is “staying.” ART suppresses the virus, but it doesn’t eliminate it. HIV hides in reservoirs throughout the body, particularly in certain immune cells, where it can sit dormant for years. The moment you stop taking medication, the virus begins replicating again from those reservoirs. Your viral load climbs, your immune cell count drops, and the risk of both illness and transmitting HIV to others returns. This is why guidelines from the U.S. Department of Health and Human Services explicitly state that ART should be continued indefinitely.
What the First Months Look Like
Most people who start ART reach viral suppression within six months. Many get there faster, though it can occasionally take longer depending on how high the viral load was at the start and individual factors like overall health and the specific medication used. During those early months, your provider will check your blood work to confirm the virus is responding to treatment and that you’re tolerating the medication well.
Once you reach an undetectable viral load (generally below 200 copies per milliliter of blood), the focus shifts to maintaining it. Routine lab visits typically become less frequent over time, often moving from every few months to every six months once you’re stably suppressed. The ongoing monitoring checks that your viral load stays undetectable and that your immune system is recovering or holding steady.
What Undetectable Means for Transmission
Reaching and maintaining an undetectable viral load has a benefit beyond your own health: it eliminates the risk of sexually transmitting HIV to a partner. Multiple large prospective studies tracking thousands of couples where one partner was living with HIV found zero transmissions when the positive partner maintained a viral load below 200 copies per milliliter. This finding is the basis of the widely endorsed U=U (Undetectable = Untransmittable) message. It’s one of the strongest motivators for staying on treatment consistently.
Daily Pills vs. Injectable Options
For most people, ART means taking one pill once a day. Modern regimens have combined multiple drugs into a single tablet, which is a major improvement over the handfuls of pills required in earlier decades. Side effects with current medications are generally mild and often resolve within the first few weeks.
If daily pills feel burdensome or hard to stick with, there’s now a long-acting injectable option. A two-drug combination given as an intramuscular injection starts with monthly doses for the first two months, then switches to once every two months. You go to a clinic for the injection and don’t need to think about pills in between. This doesn’t change the “lifelong” part of the equation, but it does change the day-to-day experience of treatment significantly.
What Happens if You Miss Doses
Consistency matters. When medication levels in your body drop because of missed doses or gaps in treatment, the virus can start replicating again. That replication isn’t just a temporary setback. HIV mutates rapidly, and when it copies itself in the presence of low (but not zero) drug levels, it can develop resistance mutations. Those mutations can make your current medication ineffective and, in some cases, cause cross-resistance to other drugs in the same class, limiting your future treatment options.
This is especially important with the long-acting injectable regimen. Because the drugs involved have long half-lives (meaning they leave your body slowly), missing or delaying an injection creates a prolonged window of low drug levels, which is an ideal environment for resistance to develop. If you’re considering the injectable option, keeping appointments on schedule is essential.
A single missed pill is not a crisis. But a pattern of inconsistent adherence is one of the most common reasons treatment fails. If you’re struggling with your regimen for any reason, whether that’s side effects, cost, scheduling, or something else, switching to a different medication or formulation is almost always possible and far better than quietly skipping doses.
Could Treatment Ever Become Temporary?
Researchers are actively working toward therapies that could allow people to stop ART while still keeping the virus controlled. A recent clinical trial at UCSF tested a combination of three experimental immunotherapies: a therapeutic vaccine to train immune cells to target hidden HIV, followed by two rounds of anti-HIV antibodies designed to reduce the viral reservoir. Seven out of ten participants maintained low viral levels for many months after stopping ART.
“I do believe we are finally making real progress towards developing a therapy that may allow people to live a healthy life without the need of lifelong medications,” said Steven Deeks, a professor of medicine at UCSF and co-senior author of the study. These results are promising but still experimental. For now, no approach has been proven to reliably replace ongoing ART, and stopping treatment outside of a clinical trial remains risky.
The honest answer today is that HIV treatment is a lifelong commitment. But the experience of that commitment has gotten remarkably easier: one pill a day or one injection every two months, minimal side effects for most people, a normal life expectancy, and zero risk of transmitting the virus to sexual partners. The duration hasn’t changed, but the weight of it has.